ICON-P – A double-blind evaluation of quality improvements with individualized CONstraints from low-cost knowledge-based radiation therapy planning in prostate cancer

Q1 Nursing
Saheli Saha , S Sriram Prasath , Balakrishnan Arun , Smita Jagadish Kalita , Niranjan Elavarasan , Debashree Guha Adhya , Arnab Sarkar , Moses Arunsingh , Santam Chakraborty , Indranil Mallick
{"title":"ICON-P – A double-blind evaluation of quality improvements with individualized CONstraints from low-cost knowledge-based radiation therapy planning in prostate cancer","authors":"Saheli Saha ,&nbsp;S Sriram Prasath ,&nbsp;Balakrishnan Arun ,&nbsp;Smita Jagadish Kalita ,&nbsp;Niranjan Elavarasan ,&nbsp;Debashree Guha Adhya ,&nbsp;Arnab Sarkar ,&nbsp;Moses Arunsingh ,&nbsp;Santam Chakraborty ,&nbsp;Indranil Mallick","doi":"10.1016/j.tipsro.2023.100206","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><p>/Objective(S)</p><p>A low-cost, prior knowledge-based individualized dose-constraint generator for organs-at-risk has been developed for prostate cancer radiation therapy (RT) planning. In this study, we aimed to evaluate the feasibility and improvements in organs-at-risk (OAR) doses in prostate cancer RT planning using this tool served on a web application.</p></div><div><h3>Materials And Methods</h3><p>A set of previously treated prostate cancer cases planned and treated with generic constraints were replanned using individualized dose constraints derived from a library of cases with similar volumes of target, OAR, and overlap regions and served on the web-based application. The goal was to assess the reduction in mean dose, specified dose volumes (V59Gy, V56Gy, V53Gy, V47Gy, and V40Gy), and generalized equivalent uniform dose (gEUD) to the rectum and bladder. Planners and assessors were blinded to the initial achieved doses and penalties. Sample size estimation was based on improvement in V53Gy for the rectum and bladder with a paired evaluation.</p></div><div><h3>Results</h3><p>Twenty-four patients were replanned. All the plans had a PTV D95 of at least 97% of the prescribed dose. The individualized OAR constraints could be met for 87.5% of patients for all dose levels. The mean dose, V59Gy, V53Gy, and V47Gy for the bladder was reduced by 7.5 Gy, 1.12%, 5.51%, and 10.53% respectively. Similarly for the rectum, the mean dose, V59Gy, V53Gy, V47Gy and was reduced by 5.5 Gy, 4.34%, 6.97%, and 11.61% respectively. All dose reductions were statistically significant. The gEUD of the bladder was reduced by 2.47 Gy (p &lt; 0.001) and the rectum by 3.21 Gy (p &lt; 0.001).</p></div><div><h3>Conclusion</h3><p>Treatment planning based on individualized dose constraints served on a web application is feasible and leads to improvement at clinically important dose volumes in prostate cancer RT planning. This application can be served publicly for improvements in RT plan quality.</p></div>","PeriodicalId":36328,"journal":{"name":"Technical Innovations and Patient Support in Radiation Oncology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8c/48/main.PMC10232660.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Technical Innovations and Patient Support in Radiation Oncology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2405632423000069","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Nursing","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose

/Objective(S)

A low-cost, prior knowledge-based individualized dose-constraint generator for organs-at-risk has been developed for prostate cancer radiation therapy (RT) planning. In this study, we aimed to evaluate the feasibility and improvements in organs-at-risk (OAR) doses in prostate cancer RT planning using this tool served on a web application.

Materials And Methods

A set of previously treated prostate cancer cases planned and treated with generic constraints were replanned using individualized dose constraints derived from a library of cases with similar volumes of target, OAR, and overlap regions and served on the web-based application. The goal was to assess the reduction in mean dose, specified dose volumes (V59Gy, V56Gy, V53Gy, V47Gy, and V40Gy), and generalized equivalent uniform dose (gEUD) to the rectum and bladder. Planners and assessors were blinded to the initial achieved doses and penalties. Sample size estimation was based on improvement in V53Gy for the rectum and bladder with a paired evaluation.

Results

Twenty-four patients were replanned. All the plans had a PTV D95 of at least 97% of the prescribed dose. The individualized OAR constraints could be met for 87.5% of patients for all dose levels. The mean dose, V59Gy, V53Gy, and V47Gy for the bladder was reduced by 7.5 Gy, 1.12%, 5.51%, and 10.53% respectively. Similarly for the rectum, the mean dose, V59Gy, V53Gy, V47Gy and was reduced by 5.5 Gy, 4.34%, 6.97%, and 11.61% respectively. All dose reductions were statistically significant. The gEUD of the bladder was reduced by 2.47 Gy (p < 0.001) and the rectum by 3.21 Gy (p < 0.001).

Conclusion

Treatment planning based on individualized dose constraints served on a web application is feasible and leads to improvement at clinically important dose volumes in prostate cancer RT planning. This application can be served publicly for improvements in RT plan quality.

Abstract Image

Abstract Image

Abstract Image

ICON-P -一项低成本、基于知识的前列腺癌放射治疗计划在个体化约束下质量改善的双盲评估
目的/目的(S)为前列腺癌症放射治疗(RT)计划开发了一种低成本、事先基于知识的针对器官风险的个体化剂量约束生成器。在这项研究中,我们的目的是评估在前列腺癌症RT计划中使用该工具在网络应用程序中的组织风险(OAR)剂量的可行性和改进。材料和方法使用个体化剂量限制对一组计划和治疗的癌症前列腺癌病例进行重新规划,这些个体化剂量约束源于具有相似数量的靶点、OAR和重叠区域的病例库,并在基于网络的应用程序上提供服务。目的是评估直肠和膀胱的平均剂量、指定剂量体积(V59Gy、V56Gy、V53Gy、V47Gy和V40Gy)以及广义等效均匀剂量(gEUD)的减少情况。规划者和评估者对最初达到的剂量和处罚视而不见。样本量估计基于直肠和膀胱V53Gy的改善,并进行配对评估。结果24例患者进行了再计划。所有计划的PTV D95至少为规定剂量的97%。87.5%的患者在所有剂量水平下都能满足个体化OAR限制。膀胱的平均剂量V59Gy、V53Gy和V47Gy分别减少了7.5Gy、1.12%、5.51%和10.53%。类似地,直肠的平均剂量V59Gy、V53Gy、V47Gy分别减少了5.5Gy、4.34%、6.97%和11.61%。所有剂量减少均具有统计学意义。膀胱的gEUD减少2.47Gy(p<0.001),直肠减少3.21Gy(p<0.01)。此应用程序可以公开提供,以提高RT计划的质量。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.10
自引率
0.00%
发文量
48
审稿时长
67 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信